Skip to content
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

Avita Medical, Inc. RCEL

8 fiscal years on record · USD · FY2025 reported · SEC filings only
$71.6M
▲ 11.5% YoY
$-48.6M
$-32.2M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 71.6M
Revenue, FY2025 · full 8-year series below
Revenue $M Net income $M
FY2025 · Revenue 71.6 · Net income -48.6
30.0M60.0M-25.0M-50.0M
2017202020242025
Compound annual growth
+27.7%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−68 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -59.4% · Net -67.8%
-500%-1000%
201720202025
ROE
FY2024 · ROE -231.0%
-100%-200%
201720202025
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -32.2
-25.0M-50.0M
201720202025

Total assetsUSD 56.4M
EquityUSD -16.6M
CashUSD 10.2M
Gross debtUSD 43.0M
Net debtUSD 32.7M
Current ratio0.57×

Equity was zero or negative — liabilities equaled or exceeded assets. No ratio is shown.

The 8-year record

8 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
RCEL, 8-year financial record
Metric 20252024202320222020201920182017
Revenue $B0.10.10.10.00.00.00.00.0
Operating income $B−0.0−0.1−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.1−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.00.00.00.00.0−0.0−0.0
Net income $B−0.0−0.1−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.1−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−1.74−2.39−1.40−1.07−1.17−2.07−1.56−1.37
Dividend / sh $◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————
ROE %—−231.0−52.9−28.2−28.3−90.2−144.0−141.8
Shares out B0.030.030.030.030.020.020.02◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 42 reconciliationsAUDITED

Reconciled in 8 of the 8 fiscal years we could check. 22 checks were skipped: the balance sheet is not tagged before 2018. 10 checks were skipped: EPS is not tagged before 2017. 10 checks were skipped: revenue is not tagged before 2017.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2016

Share this section

Download image